


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-12.32%
+2.74%
-2.18%
+19.01%
+72.29%
ABBV
AbbVie
$227.50
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
ABBV Price Performance
$216.75 (+4.96%)
$234 (-2.78%)
$222.47 (+2.26%)
$209.03 (+8.84%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
ABBV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook
ABBV has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
BUY
Date
Action
Rating
Firm
Today
Reiterate
its Overweight
Cantor Fitzgerald
Jan 27, 2026
Price Target Raised
Buy
Jan 06, 2026
Price Target Raised
Buy
Morgan Stanley
Dec 13, 2025
Reiterate
Overweight
Morgan Stanley
Dec 11, 2025
Upgrade
on ABBV
Piper Sandler
PFE
Pfizer
27.47
-0.94%
SNY
Sanofi
47.03
-4.51%
MRK
Merck Company
119.24
-0.06%
LLY
Eli Lilly and
1038.27
+2.27%
TEVA
Teva Pharma
33.92
-1.14%
What is ABBV current stock price?
What are ABBV stock strengths?
What is ABBV Risk Level?
What is ABBV market cap and volume?
What is ABBV current Stock IQ?
Should I buy ABBV stock right now?
Is ABBV a Strong Buy right now?
What does a 'Strong Buy' rating mean for ABBV?
What does a 'Strong Sell' rating mean for ABBV?
What factors influence ABBV's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-12.32%
+2.74%
-2.18%
+19.01%
+72.29%
ABBV
AbbVie
Current Price
$227.50
Runners Also Watch
PFE
Pfizer
27.47
-0.94%
SNY
Sanofi
47.03
-4.51%
MRK
Merck Company
119.24
-0.06%
LLY
Eli Lilly and
1038.27
+2.27%
TEVA
Teva Pharma
33.92
-1.14%

ABBV Price Performance
$216.75 (+4.96%)
$234 (-2.78%)
$222.47 (+2.26%)
$209.03 (+8.84%)
ABBV Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
ABBV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook
ABBV has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
BUY
Today
Reiterate
its Overweight
Cantor Fitzgerald
Jan 27, 2026
Price Target Raised
Buy
Jan 06, 2026
Price Target Raised
Buy
Morgan Stanley
Dec 13, 2025
Reiterate
Overweight
Morgan Stanley
Dec 11, 2025
Upgrade
on ABBV
Piper Sandler
ABBV Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
ABBV Latest Analysis
AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform. AbbVie Inc. (NYSE:ABBV) is one of the best long-term stocks to invest in for retirement. On February 6 Cantor Fitzgerald reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) with a $250 price target. The positive outlook follows solid fourth-quarter 2025 results as Skyrizi sales topped estimates and the company provided guidance above consensus. On February [….]
Today
Evercore ISI Cuts AbbVie Inc. (ABBV) PT Says Consensus for 2026 and 2027 Still Looks Beatable. AbbVie Inc. (NYSE:ABBV) is included among the 13 Best Roth IRA Stocks to Buy Now. On February 5 Evercore ISI analyst Gavin Clark-Gartner trimmed his price recommendation on AbbVie Inc. (NYSE:ABBV) to $228 from $232. The analyst maintained an Outperform rating on the stock. In a note to investors he said that despite Tremfya continuing [….]
Today
AbbVie sues US health agency over Botox price controls.
Wed Feb 11, 2026
P/E Ratio Insights for AbbVie. In the current market session AbbVie Inc. (NYSE:ABBV) stock price is at $222.12 after a 0.14% decrease. However over the past month the company'.s stock spiked by 0.25% and in the past year by 14.99%. Shareholders might be interested in knowing whether the stock is overvalued even if the
Wed Feb 11, 2026
Heres What Will Drive AbbVies Top-line Growth in 2026. ABBV sees 2026 revenues rising to $67B as Rinvoq and Skyrizi drive growth with neuroscience gains offsetting Humira erosion and oncology headwinds.
Tue Feb 10, 2026
Heres Why AbbVie (ABBV) is a Strong Value Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Tue Feb 10, 2026
AbbVie Q4 Earnings Review: I May Have Just Made A Huge Mistake.
Wed Feb 4, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ABBV Stock trends
ABBV Stock performance
ABBV Stock analysis
ABBV investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.